Beijing:
With regard to the vaccine developed by the Chinese pharmaceutical company Synoform against the global epidemic of corona virus, the researchers have made important revelations and declared the Chinese vaccine to be 73% useful and effective. The two-dose Conora vaccine developed by Synoform has a 73% efficacy rate.
According to details, foreign sources quoted an article published in the Journal of the American Medical Association as saying that this is the first detailed report after a large study on cyanobacterial vaccine.
According to the report, two weeks after a single dose of the vaccine, developed by a subsidiary of Cyanoform based in Wuhan, the effectiveness of the second vaccine was found to be more than 72.8 percent. In February, the Chinese company said that The vaccine has an efficacy rate of 72.5%.
According to an article published in the Journal of the American Medical Association, another vaccine, developed by an institute affiliated with the Beijing-based Synoform, was approved for emergency use by the World Health Organization (WHO) this month. The report said that the results came after vaccinating more than 40,000 people in Wuhan and Beijing.
According to an article published in the Journal of the American Medical Association, only two of the participants showed severe symptoms of Covid 19 after being vaccinated. However, no conclusions can be drawn about the effectiveness of this vaccine in terms of serious prevention.
